ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting.

Peter Gæde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.